SXTC:NASDAQ
China SXT Pharmaceuticals Inc
$3.55
arrow_upward
+0.28%(+0.0100) 1D
$3.76
arrow_upward
+5.98% (+0.21)bedtimeAfter hours
Closed: Oct 27, 4:00:00 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SXTC...
Open
$3.47
High
$4.07
Low
$3.28
Mkt. cap
2.44M
Avg. vol.
43.17M
Volume
237.05K
52-wk high
$8,375,824.00
52-wk low
$3.28
EPS
-$730.39
Beta
1.86
Shares outstanding
104.00K
No. of employees
56
Open
$3.47
High
$4.07
Low
$3.28
Mkt. cap
2.44M
Avg. vol.
43.17M
Volume
237.05K
52-wk high
$8,375,824.00
52-wk low
$3.28
EPS
-$730.39
Beta
1.86
Shares outstanding
104.00K
No. of employees
56
News stories
From web sources and news partners
TradingView
·
1 hour ago
Dow, S&P 500, Nasdaq Futures Mixed Ahead Of Key Tech Results, Fed Rate Decision: SKHY, HOOD, BA, ENPH In Focus
The Motley Fool
·
7 hours ago
S&P 500 Sell-Off: Is Now the Right Time to Buy the Dip?
investingLive
·
10 hours ago
The S&P and Nasdaq 100 are trying to tilt the bias to the upside technically
KuCoin
·
2 hours ago
Fed decision this Wednesday. Here’s why the first market
About China SXT Pharmaceuticals Inc
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
No analyst ratings found. | |||||
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
Revenue | 313.28K | 313.28K | 255.74K | 255.74K |
Cost of goods sold | 262.42K | 262.42K | 182.25K | 182.25K |
Cost of revenue | 262.42K | 262.42K | 182.25K | 182.25K |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 3.22M | 3.22M | 465.50K | 465.50K |
Operating expense | 3.22M | 3.22M | 465.50K | 465.50K |
Total operating expenses | 3.48M | 3.48M | 647.75K | 647.75K |
Operating income | -3.17M | -3.17M | -392.00K | -392.00K |
Other non operating income | 724.00 | 724.00 | 489.68K | 489.68K |
EBT including unusual items | -3.18M | -3.18M | 81.86K | 81.86K |
EBT excluding unusual items | -3.18M | -3.18M | 81.86K | 81.86K |
Income tax expense | - | - | - | - |
Effective tax rate | - | - | - | - |
Other operating expenses | - | - | - | - |
Net income | -3.18M | -3.18M | 81.86K | 81.86K |
Net profit margin | -1,016.45% | -1,016.45% | 32.01% | 32.01% |
Earnings per share | - | - | - | - |
Interest and investment income | - | - | - | - |
Interest expense | -15.66K | -15.66K | -15.82K | -15.82K |
Net interest expenses | -15.66K | -15.66K | -15.82K | -15.82K |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -3.15M | -3.15M | -371.22K | -371.22K |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events